Exosomes in Cardiovascular Disease: Emerging Roles, Therapeutic Potential and Translational Challenges
Adnan Taan Al Khafaji1, Ali Mohammed Barakat1, Akram Jooda Al Zaidy1
1College of Medicine, Al-Ayen Iraqi University, An Nasiriyah, Iraq.
Basic & Clinical Pharmacology & Toxicology
|November 30, 2025
Summary
Exosomes show promise for treating cardiovascular diseases (CVDs) by aiding heart repair. However, challenges in their isolation, standardization, and safety must be addressed for clinical use.
Area of Science:
- Cardiovascular Medicine
- Regenerative Medicine
- Biotechnology
Background:
- Cardiovascular diseases (CVDs) are a leading cause of death globally.
- Myocardial injury, adverse remodeling, and impaired cardiomyocyte regeneration are key challenges in CVDs.
- Exosomes are crucial intercellular communicators influencing cardiac health and disease.
Purpose of the Study:
- To explore the therapeutic and diagnostic potential of exosomes in cardiovascular regenerative medicine.
- To review the mechanisms by which exosomes mediate cardiac repair and regeneration.
- To identify current challenges and future directions for exosome-based cardiovascular therapies.
Main Methods:
- Review of preclinical and clinical studies on exosome therapy for CVDs.
- Analysis of exosome cargo (nucleic acids, proteins, lipids) and their roles in cardiac processes.
- Evaluation of challenges in exosome isolation, characterization, and clinical application.
Main Results:
- Exosomes, particularly from stem and immune cells, demonstrate regenerative capabilities in preclinical models.
- Exosomes modulate cytoprotection, angiogenesis, apoptosis, and immune responses critical for cardiac repair.
- Diagnostic applications of exosomes in CVD management are a nearer-term goal.
Conclusions:
- Exosomes offer a promising cell-free therapeutic strategy for cardiovascular diseases.
- Standardization of protocols, overcoming heterogeneity, and ensuring safety are crucial for clinical translation.
- Further research is needed to fully harness exosome potential in cardiovascular regenerative medicine.
Keywords:
cardiac regenerationcardiovascular diseasesexosomesintercellular communicationtherapeutic deliveryMore Related Videos
07:03Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells
Published on: September 23, 2022
2.5K
11:45Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart
Published on: January 7, 2019
7.0K
Related Concept Videos
Overview of Exosomes
3.4K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.4K
Mesenchymal Stem Cells
5.4K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.4K
